Taysha Gene Therapies News

Taysha Gene Therapies | 8-K: Current report

May 30 16:04 ET

Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 14 16:25 ET

Taysha Gene Therapies | DEFA14A: Others

Apr 18 16:27 ET

Taysha Gene Therapies | DEF 14A: Definitive information statements

Apr 18 16:19 ET

Taysha Gene Therapies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 19 16:57 ET

Taysha Gene Therapies | 8-K: Current report

Mar 19 16:22 ET

Taysha Gene Therapies | 8-K: Current report

Jan 10 00:00 ET

Taysha Gene Therapies | 8-K: Current report

Dec 20, 2023 16:21 ET

Taysha Gene Therapies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Dec 20, 2023 16:20 ET

Taysha Gene Therapies | 8-K: Current report

Nov 15, 2023 16:29 ET

Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates

Nov 14, 2023 16:47 ET

Taysha Gene Therapies | 8-K: Current report

Nov 1, 2023 16:02 ET

Taysha Gene Therapies | DEF 14A: Definitive information statements

Oct 5, 2023 07:00 ET

Taysha Gene Therapies | 8-K: Current report

Sep 26, 2023 08:08 ET

Taysha Gene Therapies | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Sep 21, 2023 16:01 ET

Taysha Gene Therapies | 8-K: Current report

Sep 19, 2023 16:09 ET

Taysha Gene Therapies | S-3: Registration statement for specified transactions by certain issuers

Aug 30, 2023 16:02 ET

Taysha Gene Therapies | 8-K: Current report

Aug 29, 2023 07:00 ET

Taysha Gene Therapies | 8-K: Current report

Aug 24, 2023 08:09 ET

Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Initial Clinical Data from First Adult Rett Syndrome Patient Dosed in REVEAL Phase 1/2 Trial and Provides Corporate Update with Second Quarter 2023 Financial Results

Aug 14, 2023 07:29 ET